Previsioni di mercato per il trattamento dell\'ematuria nell\'Asia del Pacifico fino al 2028 - Impatto del COVID-19 e analisi regionale per trattamento (farmaci, terapie e altri), indicazione (infezioni del tratto urinario, calcoli renali, uretrite, cancro del sangue, calcoli alla vescica, cancro alla prostata, cistite, traumi) , esercizio fisico intenso, malattia renale policistica, endometriosi e mestruazioni), tipo (ematuria macroscopica, ematuria microscopica, ematuria idiopatica ed ematuria da jogging), utente finale (ospedali, cliniche e centri chirurgici ambulatoriali e altri)
Introduzione al mercato
L\'ematuria è una condizione medica in cui si riscontra la presenza di sangue nelle urine . Generalmente, l\'urina non contiene globuli rossi e quindi ciò può causare problemi seri che possono anche causare calcoli renali, infezioni del tratto urinario e altre malattie ereditarie.
Inoltre, l\'ematuria ad alta prevalenza Si prevede che le indicazioni associate rafforzeranno la crescita del mercato durante il periodo di previsione. Tuttavia, i casi non diagnosticati di indicazioni associate limitano la crescita del mercato del trattamento dell\'ematuria nell\'Asia del Pacifico.
L\'epidemia di COVID-19 ha gravemente colpito l\'industria del turismo e ha imposto interruzioni della catena di approvvigionamento; inoltre, i paesi a basso reddito si trovano ad affrontare ulteriori sfide a causa della carenza di infrastrutture sanitarie. Misure restrittive sono state adottate in Corea del Sud, Malesia, Singapore, Filippine e India per prevenire la trasmissione della malattia. Tutti questi fattori hanno avuto un impatto moderato sul mercato del trattamento dell’ematuria per un breve periodo di tempo a causa delle restrizioni sulla catena di approvvigionamento e delle limitate capacità produttive. Il coinvolgimento renale nei pazienti con COVID -19 può presentare un’ampia gamma di manifestazioni, tra cui ematuria, proteinuria, piuria e danno renale acuto (AKI). È stato segnalato che la proteinuria e l’ematuria hanno una prevalenza maggiore di COVID 19 rispetto all’AKI. D’altra parte, l’AKI è attualmente un segnale inquietante dei pazienti affetti da COVID 19 ricoverati in ospedale e un importante fattore di rischio di morte. Pertanto, il mercato del trattamento dell\'ematuria è influenzato positivamente da COVID19.
Panoramica e dinamiche del mercato
Si prevede che il mercato del trattamento dell\'ematuria nell\'Asia del Pacifico raggiungerà i 257,6 milioni di dollari entro il 2028 rispetto ai 211,0 milioni di dollari del 2021; si prevede che crescerà a un CAGR del 2,9% dal 2021 al 2028. La spesa sanitaria è notevolmente aumentata a causa della crescente prevalenza di indicazioni croniche. I governi di varie economie stanno investendo sostanzialmente nel miglioramento delle infrastrutture sanitarie. Inoltre, i pazienti nelle economie sviluppate stanno diventando consapevoli dei possibili trattamenti e della disponibilità di rimborso per il trattamento dell\'ematuria. L’ematuria è tra le prime indicazioni di malattie croniche come il cancro del sangue, il cancro della vescica e il cancro del rene. Queste malattie sono coperte da varie polizze di assicurazione sanitaria che aiutano a curare facilmente i pazienti e riducono l\'onere finanziario per l\'assistenza sanitaria. Pertanto, il miglioramento della spesa sanitaria e la consapevolezza dei pazienti riguardo al trattamento stanno guidando il mercato del trattamento dell\'ematuria nell\'Asia del Pacifico.
Segmenti chiave del mercato
In termini di tipologia, il segmento dell\'ematuria macroscopica ha rappresentato la quota maggiore del mercato del trattamento dell\'ematuria nell\'Asia del Pacifico nel 2020. In termini di trattamento, il segmento dei farmaci ha rappresentato per la quota maggiore del mercato del trattamento dell’ematuria nell’Asia del Pacifico nel 2020. In termini di indicazioni, il segmento delle infezioni del tratto urinario ha rappresentato la quota maggiore del mercato del trattamento dell’ematuria nell’Asia del Pacifico nel 2020. In termini di utenti finali, il segmento degli ospedali ha rappresentato la quota maggiore del mercato del trattamento dell’ematuria nell’Asia del Pacifico nel 2020. la quota maggiore del mercato del trattamento dell\'ematuria nell\'Asia del Pacifico nel 2020.
Principali fonti e aziende elencate
Alcune delle principali fonti primarie e secondarie a cui si fa riferimento per la preparazione di questo rapporto sul mercato del trattamento dell\'ematuria nell\'Asia del Pacifico sono siti Web aziendali, relazioni annuali, relazioni finanziarie, documenti governativi nazionali e database statistici, tra cui altri. Le principali aziende elencate nel rapporto sono AstraZeneca, Bristol-Myers Squibb Company, F. HOFFMANN-LA ROCHE LTD., GlaxoSmithKline plc., Janssen Pharmaceuticals, Merck & Co., Inc., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd e Boehringer Ingelheim International GmbH.
Rapporto sui motivi per acquistare
- Comprendere il panorama del mercato del trattamento dell\'ematuria nell\'Asia del Pacifico e identificare i segmenti di mercato che probabilmente garantiranno un forte ritorno
- Comprendere il panorama di mercato in continua evoluzione e rimanere all\'avanguardia nella concorrenza
- Per pianificare in modo efficiente fusioni, acquisizioni e accordi di partnership nel mercato del trattamento dell\'ematuria nell\'Asia del Pacifico identificando i segmenti con le vendite probabili più promettenti
- Prendere decisioni aziendali consapevoli partendo da un\'analisi percettiva e completa di l\'andamento del mercato di vari segmenti
- Ottenere previsioni sui ricavi del mercato del trattamento dell\'ematuria nell\'Asia del Pacifico basate su vari segmenti per il periodo dal 2021 al 2028
SEGMENTAZIONE DEL MERCATO DEL TRATTAMENTO DELL\'EMATURIA DELL\'ASIA PACIFICO
Da Trattamento
- Farmaci
- Terapie
- Altri
Per indicazione
- Infezioni del tratto urinario
- Calcoli renali
- Uretrite
- Cancro del sangue
- Calcoli alla vescica
- Cancro alla prostata
- Cistite
- Trauma
- Esercizio fisico intenso
- Malattia renale policistica
- Endometriosi
- Mestruazioni
Per tipo
- Ematuria macroscopica
- Ematuria microscopica
- Ematuria idiopatica
- Ematuria del pareggiatore
Per utente finale
- Ospedali
- Cliniche
- Centri chirurgici ambulatoriali (ASC)
- Altri
Per Paese
- Asia Pacifico
- Cina
- Giappone
- India
- Corea del Sud
- Australia
- Resto dell\'Asia Pacifico
Società menzionate
- AstraZeneca
- Bristol-Myers Squibb Company
- F. HOFFMANN-LA ROCHE LTD.
- GlaxoSmithKline plc.
- Janssen Pharmaceuticals
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- < span>Sun Pharmaceutical Industries Ltd
- Boehringer Ingelheim International GmbH
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Hematuria Treatment Market – By Treatment
1.3.2 Asia Pacific Hematuria Treatment Market – By Indication
1.3.3 Asia Pacific Hematuria Treatment Market – By Type
1.3.4 Asia Pacific Hematuria Treatment Market – By End User
1.3.5 Asia Pacific Hematuria Treatment Market – By Country
2. Asia Pacific Hematuria Treatment Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Hematuria Treatment Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific – PEST Analysis
4.3 Experts Opinion
5. Hematuria Treatment Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 High Prevalence of Hematuria-Associated Indications
5.1.2 Increasing Awareness About Treatment Options and Improving Healthcare Expenditure
5.2 Market Restraints
5.2.1 Undiagnosed Cases of Associated Indications
5.3 Market Opportunities
5.3.1 Increasing Opportunities for Related Treatments
5.4 Future Trends
5.4.1 Rise in Preference for Advanced Therapies
5.5 Impact Analysis
6. Hematuria Treatment Market – Asia Pacific Analysis
6.1 Asia Pacific Hematuria Treatment Market Revenue Forecast and Analysis
7. Hematuria Treatment Market Revenue and Forecast To 2028 – By Treatment
7.1 Overview
7.2 Asia Pacific Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)
7.3 Drugs
7.3.1 Overview
7.3.2 Drugs: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Therapies
7.4.1 Overview
7.4.2 Therapies: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
7.5 Others
7.5.1 Overview
7.5.2 Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8. Hematuria Treatment Market Revenue and Forecast To 2028 – By Indication
8.1 Overview
8.2 Asia Pacific Hematuria Treatment Market Share by Indication 2020 & 2028 (%)
8.3 Kidney Stones
8.3.1 Overview
8.3.2 Kidney Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Urinary Tract Infections (UTI)
8.4.1 Overview
8.4.2 Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Urethritis
8.5.1 Overview
8.5.2 Urethritis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.6 Blood Cancer
8.6.1 Overview
8.6.2 Blood Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.7 Bladder Stones
8.7.1 Overview
8.7.2 Bladder Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.8 Prostate Cancer
8.8.1 Overview
8.8.2 Prostate Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.9 Cystitis
8.9.1 Overview
8.9.2 Cystitis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.10 Trauma
8.10.1 Overview
8.10.2 Trauma: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.11 Vigorous Exercise
8.11.1 Overview
8.11.2 Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.12 Polycystic Kidney Disease
8.12.1 Overview
8.12.2 Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.13 Endometriosis
8.13.1 Overview
8.13.2 Endometriosis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.14 Menstruation
8.14.1 Overview
8.14.2 Menstruation: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
9. Hematuria Treatment Market Revenue and Forecast To 2028 – By Type
9.1 Overview
9.2 Asia Pacific Hematuria Treatment Market, By Type 2020 & 2028 (%)
9.3 Macroscopic Hematuria
9.3.1 Overview
9.3.2 Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.4 Microscopic Hematuria
9.4.1 Overview
9.4.2 Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.5 Idiopathic Hematuria
9.5.1 Overview
9.5.2 Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.6 Jogger’s Hematuria
9.6.1 Overview
9.6.2 Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
10. Hematuria Treatment Market Revenue and Forecast To 2028 – By End User
10.1 Overview
10.2 Asia Pacific Hematuria Treatment Market Share by End User 2020 & 2028 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Clinics
10.4.1 Overview
10.4.2 Clinics: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.5 Ambulatory Surgical Centers (ASC’s)
10.5.1 Overview
10.5.2 Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.6 Others
10.6.1 Overview
10.6.2 Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
11. Asia Pacific Hematuria Treatment Market – Geographic Analysis
11.1 Asia Pacific: Hematuria Treatment Market
11.1.1 Overview
11.1.2 Asia Pacific: Hematuria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
11.1.3 Asia Pacific: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
11.1.4 Asia Pacific: Hematuria Treatment Market, by Indication, 2019–2028 (US$ Million)
11.1.5 Asia Pacific: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.1.6 Asia Pacific: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)
11.1.7 Asia Pacific: Hematuria Treatment Market, by Country, 2021 & 2028 (%)
11.1.7.1 China: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.1 China: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.2 China: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.3 China: Hematuria Treatment Market, by Indication, 2019–2028 (US$ Million)
11.1.7.1.4 China: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.1.7.1.5 China: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)
11.1.7.2 Japan: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.1 Japan: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.2 Japan: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.3 Japan: Hematuria Treatment Market, by Indication, 2019–2028 (US$ Million)
11.1.7.2.4 Japan: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.1.7.2.5 Japan: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)
11.1.7.3 India: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.1 India: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.2 India: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.3 India: Hematuria Treatment Market, by Indication, 2019–2028 (US$ Million)
11.1.7.3.4 India: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.1.7.3.5 India: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)
11.1.7.4 South Korea: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.4.1 South Korea: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.4.2 South Korea: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
11.1.7.4.3 South Korea: Hematuria Treatment Market, by Indication, 2019–2028 (US$ Million)
11.1.7.4.4 South Korea: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.1.7.4.5 South Korea: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)
11.1.7.5 Australia: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.5.1 Australia: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.5.2 Australia: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
11.1.7.5.3 Australia: Hematuria Treatment Market, by Indication, 2019–2028 (US$ Million)
11.1.7.5.4 Australia: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.1.7.5.5 Australia: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)
11.1.7.6 Rest of Asia Pacific: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.6.1 Rest of Asia Pacific: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.6.2 Rest of Asia Pacific: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
11.1.7.6.3 Rest of Asia Pacific: Hematuria Treatment Market, by Indication, 2019–2028 (US$ Million)
11.1.7.6.4 Rest of Asia Pacific: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.1.7.6.5 Rest of Asia Pacific: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)
12. Impact Of COVID-19 Pandemic on Hematuria Treatment Market
12.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
13. Hematuria Treatment Market–Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 AstraZeneca
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Bristol-Myers Squibb Company
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 F. HOFFMANN-LA ROCHE LTD.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 GlaxoSmithKline Plc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Janssen Pharmaceuticals
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Merck & Co., Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Novartis AG
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Pfizer Inc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Sun Pharmaceutical Industries Ltd
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Boehringer Ingelheim International GmbH
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 2. Asia Pacific: Hematuria Treatment Market, by Indication– Revenue and Forecast to 2028 (US$ Million)
Table 3. Asia Pacific: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 4. Asia Pacific: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5. China: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 6. China: Hematuria Treatment Market, by Indication– Revenue and Forecast to 2028 (US$ Million)
Table 7. China: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. China: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 9. Japan: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 10. Japan: Hematuria Treatment Market, by Indication– Revenue and Forecast to 2028 (US$ Million)
Table 11. Japan: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 12. Japan: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 13. India: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 14. India: Hematuria Treatment Market, by Indication– Revenue and Forecast to 2028 (US$ Million)
Table 15. India: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 16. India: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. South Korea: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 18. South Korea: Hematuria Treatment Market, by Indication– Revenue and Forecast to 2028 (US$ Million)
Table 19. South Korea: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 20. South Korea: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 21. Australia: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 22. Australia: Hematuria Treatment Market, by Indication– Revenue and Forecast to 2028 (US$ Million)
Table 23. Australia: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 24. Australia: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 25. Rest of Asia Pacific: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 26. Rest of Asia Pacific: Hematuria Treatment Market, by Indication– Revenue and Forecast to 2028 (US$ Million)
Table 27. Rest of Asia Pacific: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 28. Rest of Asia Pacific: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 29. Organic Developments Done by Companies
Table 30. Inorganic Developments Done by Companies
Table 31. Glossary of Terms, Hematuria Treatment Market
LIST OF FIGURES
Figure 1. Hematuria Treatment Market Segmentation
Figure 2. Asia Pacific Hematuria Treatment Market Overview
Figure 3. Macroscopic Hematuria Segment Held the Largest Share of the Type Segment in Hematuria Treatment Market
Figure 4. India to Show Significant Growth During Forecast Period
Figure 5. Asia Pacific Hematuria Treatment Market, Industry Landscape
Figure 6. Asia Pacific PEST Analysis
Figure 7. Hematuria Treatment Market Impact Analysis of Drivers and Restraints
Figure 8. Asia Pacific Hematuria Treatment Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. Asia Pacific Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)
Figure 10. Drugs: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 11. Therapies: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 12. Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 13. Asia Pacific Hematuria Treatment Market Share by Indication 2020 & 2028 (%)
Figure 14. Kidney Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 15. Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 16. Urethritis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 17. Blood Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 18. Bladder Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 19. Prostate Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 20. Cystitis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 21. Trauma: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 22. Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 23. Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 24. Endometriosis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 25. Menstruation: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 26. Asia Pacific Hematuria Treatment Market, by Type 2020 & 2028 (%)
Figure 27. Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 28. Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 29. Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 30. Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 31. Asia Pacific Hematuria Treatment Market Share by End User 2020 & 2028 (%)
Figure 32. Hospitals: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 33. Clinics: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 34. Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 35. Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 36. Asia Pacific: Hematuria Treatment Market, by Key Country – Revenue (2021) (US$ Million)
Figure 37. Asia Pacific: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Million)
Figure 38. Asia Pacific: Hematuria Treatment Market, by Country, 2021 & 2028 (%)
Figure 39. China: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. Japan: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. India: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. South Korea: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. Australia: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. Rest of Asia Pacific: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Impact Of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 46. Growth Strategies Done by the Companies in the Market, (%)- AstraZeneca
- Bristol-Myers Squibb Company
- F. HOFFMANN-LA ROCHE LTD.
- GlaxoSmithKline plc.
- Janssen Pharmaceuticals
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd
- Boehringer Ingelheim International GmbH
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific hematuria treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific hematuria treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.